N/A N=142 Device Feasibility

Data Collection for Next Generation Ultrasound Technology Development

Endstage Renal Disease

Bottom Line

View on ClinicalTrials.gov: NCT02946229 ↗

Enrolled (actual)

142

Serious AEs

0.0%

Results posted

Nov 2018

Primary outcome: Primary: Number of Diagnostic Ultrasound Exams — 142 Participants

Study Design & Population

Study type: Interventional
Phase: N/A
Interventions: Ultrasound scan (Device)
Age: Adult, Older Adult · 18+ yrs
Sex: All
Sponsor: GE Healthcare
Primary completion: Dec 2016

Outcome Measures

Outcome	Result	p-value
PRIMARY Number of Diagnostic Ultrasound Exams	142	—

Summary

The study is designed to collect data from a ultrasound device being used to evaluate feasibility of next generation algorithms for ultrasound data processing and does not test any health outcome.

Eligibility Criteria

Inclusion Criteria

Are adults (aged 18 years of age or older) at the time of consent;
Are undergoing maintenance hemodialysis (MHD); AND
Are able and willing to provide written informed consent for participation

Exclusion Criteria

Have anatomical characteristics or comorbid medical conditions that prevent completion of ultrasound scanning using the study device; OR
Are potentially put at additional risk by participating, in the opinion of the investigator.

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02946229). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.